← Evidence map

ArticleNature cancer2025

TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancers.

Jiaxin Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41429932